GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chordia Therapeutics Inc (TSE:190A) » Definitions » Preferred Dividends

Chordia Therapeutics (TSE:190A) Preferred Dividends : 円0.00 Mil (TTM As of Feb. 2025)


View and export this data going back to 2024. Start your Free Trial

What is Chordia Therapeutics Preferred Dividends?

Preferred dividend is a dividend that is accrued and paid on a company's preferred shares. Chordia Therapeutics's preferred dividends for the three months ended in Feb. 2025 was 円0.00 Mil. Its preferred dividends for the trailing twelve months (TTM) ended in Feb. 2025 was 円0.00 Mil.

Chordia Therapeutics Preferred Dividends Historical Data

The historical data trend for Chordia Therapeutics's Preferred Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chordia Therapeutics Preferred Dividends Chart

Chordia Therapeutics Annual Data
Trend Aug21 Aug22 Aug23 Aug24
Preferred Dividends
- - - -

Chordia Therapeutics Quarterly Data
Aug21 Aug22 May23 Aug23 May24 Aug24 Feb25
Preferred Dividends Get a 7-Day Free Trial - - - - -

Chordia Therapeutics Preferred Dividends Calculation

A dividend that is accrued and paid on a company's preferred shares.

Chordia Therapeutics  (TSE:190A) Preferred Dividends Explanation

In the event that a company is unable to pay all dividends, claims to preferred dividends take precedence over claims to dividends that are paid on common shares.

Preferred Dividends for the trailing twelve months (TTM) ended in Feb. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chordia Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chordia Therapeutics Inc (TSE:190A) » Definitions » Preferred Dividends
Comparable Companies
TSE:4978 TSE:4588 TSE:4575 TSE:7096 TSE:4880 TSE:4599 TSE:7776 TSE:4888 TSE:4579 TSE:4563 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
2-26-1 Muraoka-Higashi, Kanagawa, Fujisawa, JPN, 251-0012
Website
https://www.chordiatherapeutics.com
Chordia Therapeutics Inc is a bio-venture company specializing in cancer research and development. Its mission is to deliver first-in-class cancer drugs to patients. It is a clinical-stage biotech company engaged in researching and developing novel therapies for cancers with high unmet medical needs.

Chordia Therapeutics Headlines

No Headlines